The β-Hemolysin and Intracellular Survival of Streptococcus agalactiae in Human Macrophages

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Sagar, Anubha ^a   Klemm, Carolin ^a   Hartjes, Lara ^a   Mauerer, Stefanie ^a   van Zandbergen, Ger ^b   Spellerberg, Barbara ^a  

^a UNIVERSITY OF ULM   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA HEMOLYSIN; CYTOCHALASIN D; HEMOLYSIN; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL REPRODUCTION; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM MUTANT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; GRANULOCYTE; HUMAN; HUMAN CELL; INTRACELLULAR BACTERIUM; MACROPHAGE; MONOCYTE; NONHUMAN; STRAIN DIFFERENCE; STREPTOCOCCUS AGALACTIAE;

BACTERIAL PROTEINS; CELL LINE; CELL WALL; CYTOCHALASIN D; CYTOKINES; HEMOLYSIN PROTEINS; HUMANS; INFLAMMATION MEDIATORS; INTRACELLULAR SPACE; MACROPHAGES; PHAGOCYTES; PHAGOCYTOSIS; STREPTOCOCCUS AGALACTIAE; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 84875940991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060160     Document Type: Article

References (39)

1. Luck S, Torny M, d'Agapeyeff K, Pitt A, Heath P, et al. (2003) Estimated early-onset group B streptococcal neonatal disease. Lancet 361: 1953-1954.
2. Zangwill K, Schuchat A, Wenger JD, (1992) Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR 41(No (SS-6): 25-32.
3. Morinis J, Shah J, Murthy P, Fulford M, (2011) Horizontal transmission of group B streptococcus in a neonatal intensive care unit. Paediatr Child Health 16: e48-50.
4. Farley MM, (1995) Group B streptococcal infection in older patients. Spectrum of disease and management strategies. Drugs Aging 6: 293-300.
5. Nizet V, Gibson R, Chi E, Framson P, Hulse M, et al. (1996) Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun 64: 3818-3826.
6. Doran KS, Liu GY, Nizet V, (2003) Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Invest 112: 736-744.
7. Liu GY, Doran KS, Lawrence T, Turkson N, Puliti M, et al. (2004) Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc Natl Acad Sci U S A 101: 14491-14496.
8. Sendi P, Johansson L, Dahesh S, Van-Sorge NM, Darenberg J, et al. (2009) Bacterial phenotype variants in group B streptococcal toxic shock syndrome. Emerg Infect Dis 15: 223-232.
9. Jiang SM, Cieslewicz MJ, Kasper DL, Wessels MR, (2005) Regulation of virulence by a two-component system in group B streptococcus. J Bacteriol 187: 1105-1113.
10. Spellerberg B, Pohl B, Haase G, Martin S, Weber-Heynemann J, et al. (1999) Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition. J Bacteriol 181: 3212-3219.
11. Gottschalk B, Broker G, Kuhn M, Aymanns S, Gleich-Theurer U, et al. (2006) Transport of multidrug resistance substrates by the Streptococcus agalactiae hemolysin transporter. J Bacteriol 188: 5984-5992.
12. Aymanns S, Mauerer S, van Zandbergen G, Wolz C, Spellerberg B, (2011) High-level fluorescence labeling of gram-positive pathogens. PLoS One 6: e19822.
13. Schwende H, Fitzke E, Ambs P, Dieter P, (1996) Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol 59: 555-561.
14. Esmann L, Idel C, Sarkar A, Hellberg L, Behnen M, et al. (2010) Phagocytosis of apoptotic cells by neutrophil granulocytes: diminished proinflammatory neutrophil functions in the presence of apoptotic cells. J Immunol 184: 391-400.
15. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A, (1994) Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 62: 2715-2721.
16. Doran KS, Chang JC, Benoit VM, Eckmann L, Nizet V, (2002) Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8. J Infect Dis 185: 196-203.
17. Rubens CE, Smith S, Hulse M, Chi EY, van Belle G, (1992) Respiratory cell invasion by group B streptococci. Infect Immun 60: 5157-5163.
18. Vallejo JG, Bake RCJ, Edwards MS, (1996) Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci. Infect Immun 64: 5042-5046.
19. Lamy MC, Zouine M, Fert J, Vergassola M, Couve E, et al. (2004) CovS/CovR of group B streptococcus: a two-component global regulatory system involved in virulence. Mol Microbiol 54: 1250-1268.
20. Fettucciari K, Rosati E, Scaringi L, Cornacchione P, Migliorati G, et al. (2000) Group B Streptococcus induces apoptosis in macrophages. J Immunol 165: 3923-3933.
21. Ulett GC, Maclean KH, Nekkalapu S, Cleveland JL, Adderson EE, (2005) Mechanisms of group B streptococcal-induced apoptosis of murine macrophages. J Immunol 175: 2555-2562.
22. Laskay T, van Zandbergen G, Solbach W, (2003) Neutrophil granulocytes-Trojan horses for Leishmania major and other intracellular microbes? Trends Microbiol 11: 210-214.
23. Thwaites GE, Gant V, (2011) Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? Nat Rev Microbiol 9: 215-222.
24. Hertzen E, Johansson L, Kansal R, Hecht A, Dahesh S, et al. (2012) Intracellular Streptococcus pyogenes in human macrophages display an altered gene expression profile. PLoS One 7: e35218.
25. Schwan WR, Langhorne MH, Ritchie HD, Stover CK, (2003) Loss of hemolysin expression in Staphylococcus aureus agr mutants correlates with selective survival during mixed infections in murine abscesses and wounds. FEMS Immunol Med Microbiol 38: 23-28.
26. Littmann M, Albiger B, Frentzen A, Normark S, Henriques-Normark B, et al. (2009) Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression. EMBO Mol Med 1: 211-222.
27. Harvey RM, Ogunniyi AD, Chen AY, Paton JC, (2011) Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood. Infect Immun 79: 4122-4130.
28. Valenti-Weigand P, Benkel P, Rohde M, Chhatwal GS, (1996) Entry and intracellular survival of group B streptococci in J774 macrophages. Infect Immun 64: 2467-2473.
29. Fettucciari K, Quotadamo F, Noce R, Palumbo C, Modesti A, et al. (2011) Group B Streptococcus (GBS) disrupts by calpain activation the actin and microtubule cytoskeleton of macrophages. Cell Microbiol 13: 859-884.
30. Gibson RL, Lee MK, Soderland C, Chi EY, Rubens CE, (1993) Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion. Infect Immun 61: 478-485.
31. Greco R, DeMartino L, Donnarumma G, Conte M, Seganti L, et al. (1995) Invasion of cultured human cells by Streptococcus pyogenes. Res Microbiol 146: 551-560.
32. Lemire P, Houde M, Lecours MP, Fittipaldi N, Segura M, (2012) Role of capsular polysaccharide in Group B Streptococccus interactions with dendritic cells. Microbes Infect 14: 1064-1076.
33. Cumley NJ, Smith LM, Anthony M, May RC, (2012) The CovS/CovR acid response regulator is required for intracellular survival of group B Streptococcus in macrophages. Infect Immun 80: 1650-1661.
34. Teixeira CF, Azevedo NL, Carvalho TM, Fuentes J, Nagao PE, (2001) Cytochemical study of Streptococcus agalactiae and macrophage interaction. Microsc Res Tech 54: 254-259.
35. Portnoy DA, Chakraborty T, Goebel W, Cossart P, (1992) Molecular determinants of Listeria monocytogenes pathogenesis. Infect Immun 60: 1263-1267.
36. Fan H, Williams DL, Zingarelli B, Breuel KF, Teti G, et al. (2007) Differential regulation of lipopolysaccharide and Gram-positive bacteria induced cytokine and chemokine production in macrophages by Galpha(i) proteins. Immunology 122: 116-123.
37. Kwak DJ, Augustine NH, Borges WG, Joyner JL, Green WF, et al. (2000) Intracellular and extracellular cytokine production by human mixed mononuclear cells in response to group B streptococci. Infect Immun 68: 320-327.
38. Givner LB, Gray L, O'Shea TM, (1995) Antibodies to tumor necrosis factor-alpha: use as adjunctive therapy in established group B streptococcal disease in newborn rats. Pediatr Res 38: 551-554.
39. Trieu-Cuot P, Carlier C, Poyart-Salmeron C, Courvalin P, (1990) A pair of mobilizable shuttle vectors conferring resistance to spectinomycin for molecular cloning in Escherichia coli and in Gram-positive bacteria. Nucleic Acids Res 18: 4296.